In our study, we implanted primary tumor pieces from 78 untreated patients (ranging from GS6-GS9) into the male NOD/SCID, Rag2, or NSG mice supplemented with testosterone at 3 different sites (i.e., SC, KC and/or AP) (Table 1 and Table S3). The gene discussed is CALCA; the disease is neoplasm.